B cell responses: cell interaction dynamics and decisions

JG Cyster, CDC Allen - Cell, 2019 - cell.com
B cells and the antibodies they produce have a deeply penetrating influence on human
physiology. Here, we review current understanding of how B cell responses are initiated; the …

Rituximab for the treatment of multiple sclerosis: a review

CG Chisari, E Sgarlata, S Arena, S Toscano, M Luca… - Journal of …, 2022 - Springer
In the last decades, evidence suggesting the direct or indirect involvement of B cells on
multiple sclerosis (MS) pathogenesis has accumulated. The increased amount of data on …

Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis

I Jelcic, F Al Nimer, J Wang, V Lentsch, R Planas… - Cell, 2018 - cell.com
Multiple sclerosis is an autoimmune disease that is caused by the interplay of genetic,
particularly the HLA-DR15 haplotype, and environmental risk factors. How these etiologic …

[HTML][HTML] GM-CSF in inflammation

JA Hamilton - Journal of Experimental Medicine, 2020 - rupress.org
Granulocyte–macrophage colony-stimulating factor (GM-CSF) has many more functions
than its original in vitro identification as an inducer of granulocyte and macrophage …

HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis

J Wang, I Jelcic, L Mühlenbruch, V Haunerdinger… - Cell, 2020 - cell.com
The HLA-DR15 haplotype is the strongest genetic risk factor for multiple sclerosis (MS), but
our understanding of how it contributes to MS is limited. Because autoreactive CD4+ T cells …

Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?

WH Fridman, S Sibéril, G Pupier, S Soussan… - Seminars in …, 2023 - Elsevier
Whereas T cells in the tumor microenvironment have been the main focus as cancer
controlling cells and targets of immunotherapies, B cells have recently gained strong …

Immunology of multiple sclerosis

M Sospedra, R Martin - Seminars in neurology, 2016 - thieme-connect.com
Multiple sclerosis (MS) is considered a prototypic autoimmune disease of the central
nervous system (CNS). A complex genetic background with the HLA-DR15 haplotype as the …

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives

M Margoni, P Preziosa, M Filippi, MA Rocca - Journal of Neurology, 2022 - Springer
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative
disease affecting the central nervous system (CNS), often characterized by the accumulation …

Dimethyl fumarate treatment mediates an anti-inflammatory shift in B cell subsets of patients with multiple sclerosis

R Li, A Rezk, M Ghadiri, F Luessi, F Zipp… - The Journal of …, 2017 - journals.aai.org
The therapeutic mode of action of dimethyl fumarate (DMF), approved for treating patients
with relapsing-remitting multiple sclerosis, is not fully understood. Recently, we and others …

Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease

AC Flach, T Litke, J Strauss, M Haberl… - Proceedings of the …, 2016 - National Acad Sciences
Multiple sclerosis (MS) is caused by T cells that are reactive for brain antigens. In
experimental autoimmune encephalomyelitis, the animal model for MS, myelin-reactive T …